Emotion-Focused Therapy for Prolonged Grief Disorder
Official title: Emotion-Focused Therapy in the Treatment of Prolonged Grief Disorder: Study Protocol for a Randomised Controlled Trial
Run by Universidad Pontificia Comillas · NCT07207512 · Data updated 2026-11-12
This trial tests whether Emotion-Focused Therapy helps adults with Prolonged Grief Disorder feel less grief after 8 to 10 weekly therapy sessions or through a self-guided EFT-based program.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 128 (estimated) |
| Sponsor | Universidad Pontificia Comillas Academic / other |
| Locations | 1 site (Madrid, Madrid) |
| Status | Recruiting |
| Started | April 6, 2026 |
| Main results expected | September 1, 2029 |
| Study ends | September 1, 2029 |
| Registry record updated | September 2, 2026 |
| Trial ID | NCT07207512 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 years or older with Prolonged Grief Disorder who lost a loved one at least six months ago and meet ICD-11 criteria, able to provide consent, and on stable medications.
✕Probably not a fit
Individuals with active psychosis, substance use disorders, eating disorders, imminent suicide risk, or recent bereavement (<6 months) may not benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults who have lost a loved one at least six months ago and meet criteria for Prolonged Grief Disorder are randomized to receive either in-person Emotion-Focused Therapy for grief over 8–10 weekly sessions or a 10-week self-help program based on EFT. The study uses questionnaires to measure grief, mood, and well-being before, during, and after the intervention. Primary aims are to see if EFT reduces grief symptoms and whether it also affects anxiety, depression, trauma, and overall distress. The trial is conducted at UNINPSI in Madrid under the lead sponsorship of Universidad Pontificia Comillas, with participants required to have stable medications and no active concurrent psychological treatment.
Why it matters
Potential benefit: If successful, EFT could lessen grief symptoms and improve mood and functioning for adults with PGD.
How similar studies have gone: Previous research in EFT-related grief work has shown promise, but this study adapts EFT specifically for PGD with a randomized design and a self-help comparison.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults (≥18 years). * Undergoing a grief process (including perinatal grief). * Meeting ICD-11 diagnostic criteria for Prolonged Grief Disorder, assessed with the Traumatic Grief Inventory - Clinician Administered (TGI-CA); death occurred six months or more prior to assessment; PG-13-R score ≥30. * Provision of informed consent. * Stable psychopharmacological medication for at least six weeks prior to therapy onset, with physician approval to maintain stability during the intervention. Exclusion Criteria: * Concurrent psychological treatment * Bereavement occurring less than six months prior to the loss * Substance abuse * Eating disorder * Psychosis; * Organic brain syndrome * Suicide risk * Risk of harm to others.
Where it's running
-
Unidad Clínica de Psicología de la Universidad Pontificia Comillas (UNINPSI)
Madrid, Madrid, Spain Recruiting
Study contacts
- Principal investigator: José Gamoneda, PhD — Universidad Pontificia Comillas
- Study coordinator: José Gamoneda, PhD
- Email: jgamoneda@comillas.edu
- Phone: +34636894995
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Technology-supported treatments for prolonged grief (PGD)
We will test two internet-based ways of delivering GROw for adults with prolonged grief—one blended with therapist video sessions and one self-guided format supported by app prompts—compared with a waiting list.
-
Ovarian suppression combined with exercise and nutrition for breast cancer treatment
This study is testing whether a program that combines exercise, healthy eating, and emotional support can help premenopausal women with localized breast cancer manage their weight and improve their overall health while they undergo ovarian suppression therapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.